Carl Zeiss Meditec AG (ETR:AFX – Get Free Report)’s stock price reached a new 52-week low during trading on Monday . The stock traded as low as €61.25 ($66.58) and last traded at €62.25 ($67.66), with a volume of 89963 shares changing hands. The stock had previously closed at €62.25 ($67.66).
Carl Zeiss Meditec Price Performance
The firm has a 50-day simple moving average of €77.97 and a 200 day simple moving average of €96.69. The company has a debt-to-equity ratio of 6.74, a current ratio of 3.51 and a quick ratio of 2.47. The company has a market capitalization of $5.57 billion, a PE ratio of 21.25, a price-to-earnings-growth ratio of 3.45 and a beta of 0.93.
About Carl Zeiss Meditec
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Featured Stories
- Five stocks we like better than Carl Zeiss Meditec
- What is the Australian Securities Exchange (ASX)
- Intuitive Surgical Stock Outperforms Market: Highs on the Horizon
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Has This Leading Tech Stock Halted the AI Surge?
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Revolutionary Battery Stock Gains Momentum with 3D Silicon-Anodes
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
